James Ralston MD, MPH, is an internal medicine physician and senior investigator in health services and health informatics. His research mission is improving the health and care of patients living with common ongoing illnesses. His current areas of emphasis include understanding and honoring the priorities of patients living with multiple chronic conditions.
Dr. Ralston’s research focuses on developing and evaluating communication technologies that foster continuous care and a closer connection between patients and primary care teams. His commitment to finding effective ways to redesign care spans all stages of research, from project development to complete translation of results into clinical practice.
Examples of Dr. Ralston’s research projects include:
Dr. Ralston is also a University of Washington affiliate professor in health services and biomedical informatics, where he serves on the committees of PhD and master’s degree students.
Goldberg HI, Ralston JD, Hirsch IB, Hoath JI, Ahmed KI. Using an Internet comanagement module to improve the quality of chronic disease care. Jt Comm J Qual Saf. 2003;29(9):443-51. PubMed
Ralston JD, Taylor VM, Yasui Y, Kuniyuki A, Jackson JC, Tu SP. Knowledge of cervical cancer risk factors among Chinese immigrants in Seattle. J Community Health. 2003;28(1):41-57. PubMed
Ralston JD, Hampson NB. Incidence of severe unintentional carbon monoxide poisoning differs across racial/ethnic categories. Public Health Rep. 2000;115(1):46-51. PubMed
Zapata O, Ralston J, Beltran C, Parys JB, Chen JL, Longo FJ, Darszon A. Inositol triphosphate receptors in sea urchin sperm. Zygote. 1997;5(4):355-64. PubMed
A new federal rule requiring physicians to give patients access to their notes may be easier to follow than physicians expected.
KPWHRI researchers uncover obstacles faced by smaller practices when adding CVD risk calculators into primary care.
Amy Lee describes how the LHS Program is helping KP Washington track and improve treatment for opioid use disorder.
All Washington members are invited to be part of research that could improve health for millions.
The Valuing Important Things in Active Lives (VITAL) study is a three-year project funded by the Agency for Healthcare Research and quality.
Learn about the VITAL study.
Medscape, April 29, 2021